Canopy Growth Corporation (CGC) vs Lifecore Biomedical, Inc. (LFCR)

Canopy Growth Corporation and Lifecore Biomedical, Inc. are both Drug Manufacturers Specialty & Generic companies. Canopy Growth Corporation is the larger, with a market value of $311.2M against $244.1M — 1.3× the size. Canopy Growth Corporation grew revenue faster over the last twelve months: 7.80% against −10.0%. Lifecore Biomedical, Inc. has the higher net margin (−37.5% vs −80.4%) and the higher return on invested capital (−2.80% vs −17.2%). Across the 17 metrics below, Lifecore Biomedical, Inc. leads on 12 and Canopy Growth Corporation on 5.

Valuation

Metric CGC LFCR Drug Manufacturers Specialty & Generic median
P/E n/m n/m 19.25
P/S 1.41 2.00 2.11
P/B 0.60 n/m 1.78
Price to free cash flow n/m n/m 16.14
EV/EBITDA n/m n/m 12.58
EV/Sales 1.07 3.41 2.73
Earnings yield (62.58%) (15.20%) (4.38%)
Free cash flow yield (20.24%) (2.11%) 0.00%

Profitability

Metric CGC LFCR Drug Manufacturers Specialty & Generic median
Gross margin 25.16% 26.86% 53.94%
Operating margin (54.89%) (6.89%) 0.00%
Net margin (80.39%) (37.54%) 0.00%
Free cash flow margin (28.34%) (4.24%) 0.00%
Return on equity (40.14%) 201.15% (0.40%)
Return on assets (23.54%) (19.32%) (3.32%)
Return on invested capital (17.19%) (2.80%) 0.00%

Growth

Metric CGC LFCR Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) 7.80% (10.03%) 10.01%
EPS growth (last fiscal year) 84.00% (439.33%) 49.06%
Revenue growth, 5-year CAGR (13.04%) (4.24%) 6.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CGC LFCR Drug Manufacturers Specialty & Generic median
Debt to equity 0.35 11.50 0.05
Current ratio 3.04 3.87 2.31
Net debt to EBITDA 1.09 (15.59) 0.97

Dividend

Metric CGC LFCR Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.57%
Payout ratio — — 0.27

Size

Metric CGC LFCR Drug Manufacturers Specialty & Generic median
Market cap 311.15m 244.12m 276.90m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack